Silk Road Medical Inc . (NASDAQ:SILK) reported Q4 EPS of ($0.34), $0.04 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $37.35 million.
Silk Road Medical Inc . (NASDAQ:SILK) reported Q4 EPS of ($0.34), $0.04 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $37.35 million.